GSK2330672; linerixibat

Non Chimik:

Asid pentandioik, 3-((((3R,5R)-3-butil-3-etil-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-) benzotiazepin-8-il)metil)amino)-

Kòd SMILES:

O=C(O)CC(NCC1=C(OC)C=C(C2=C1)[C@@H](C3=CC=CC=C3)N[C@](CC)(CCCC)CS2( =O)=O)CC(O)=O

Kòd InChi:

InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15- 26(33)34)23(37-3)16-22(24)2 7(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2, 1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1

InChi kle:

CZGVOBIGEBDYTP-VSGBNLITSA-N

Mot:

1345982-69-5；CAS:1345982-69-5；CAS:1345982-69-5；GSK-2330672; GSK 2330672; GSK2330672; linerixibat

Solibilite:Soluble nan DMSO

Depo:Sèk, nwa ak nan 0 - 4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).

Deskripsyon:

Linerixibat (GSK2330672) se yon trè efikas, ki pa absòbe, ak oralman aktif sodyòm depandan bile asid transpòtè (ASBT).

Sib: ASBT